- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnosis and Treatment of Multiple Sclerosis
Authors
Keywords
-
Journal
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 325, Issue 8, Pages 765
Publisher
American Medical Association (AMA)
Online
2021-02-24
DOI
10.1001/jama.2020.26858
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study
- (2020) Robert T. Naismith et al. CNS DRUGS
- Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis
- (2020) Ruth Dobson et al. Multiple Sclerosis and Related Disorders
- Ofatumumab versus Teriflunomide in Multiple Sclerosis
- (2020) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Bruce A C Cree et al. LANCET NEUROLOGY
- Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
- (2019) J. William L. Brown et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis
- (2019) Richard K. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The prevalence of MS in the United States
- (2019) Mitchell T. Wallin et al. NEUROLOGY
- Intracerebral haemorrhage during alemtuzumab administration
- (2019) Christina J Azevedo et al. LANCET NEUROLOGY
- Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
- (2019) Diego Cadavid et al. LANCET NEUROLOGY
- Pain Management in Multiple Sclerosis: a Review of Available Treatment Options
- (2019) Talal Aboud et al. Current Treatment Options in Neurology
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial
- (2019) Jeffrey A Cohen et al. LANCET NEUROLOGY
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
- (2019) Giancarlo Comi et al. LANCET NEUROLOGY
- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs—A Systematic Review
- (2019) Rolfes et al. Journal of Clinical Medicine
- Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy
- (2018) Ilya Kister et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Psychiatric comorbidity is associated with disability progression in multiple sclerosis
- (2018) Kyla A. McKay et al. NEUROLOGY
- Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis
- (2018) Violaine K. Harris et al. EBioMedicine
- Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome
- (2018) Roos M. van der Vuurst de Vries et al. JAMA Neurology
- The frequency of dysphagia and its impact on adults with multiple sclerosis based on patient-reported questionnaires
- (2018) Dalal Alali et al. Multiple Sclerosis and Related Disorders
- Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
- (2017) Ari J Green et al. LANCET
- Alemtuzumab CARE-MS II 5-year follow-up
- (2017) Alasdair J. Coles et al. NEUROLOGY
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unknown
- (2016) ANNALS OF NEUROLOGY
- Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study
- (2016) Ilya Kister et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis
- (2016) Frédéric Sedel et al. NEUROPHARMACOLOGY
- Unknown
- (2016) BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Unknown
- (2015) ANNALS OF NEUROLOGY
- Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial
- (2015) Emmanuelle Le Page et al. LANCET
- Multiple sclerosis and pregnancy in the 'treatment era'
- (2015) Sandra Vukusic et al. Nature Reviews Neurology
- Effect of comorbidity on mortality in multiple sclerosis
- (2015) Ruth Ann Marrie et al. NEUROLOGY
- Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial
- (2015) G. L. Mancardi et al. NEUROLOGY
- Cardiorespiratory fitness and brain volume and white matter integrity: The CARDIA Study
- (2015) N. Zhu et al. NEUROLOGY
- High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)
- (2015) Richard A. Nash et al. JAMA Neurology
- Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b
- (2015) Kathryn C. Fitzgerald et al. JAMA Neurology
- B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation
- (2015) Laure Michel et al. Frontiers in Immunology
- The Underdiagnosis of Sleep Disorders in Patients with Multiple Sclerosis
- (2014) Steven D. Brass et al. Journal of Clinical Sleep Medicine
- Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Christian Confavreux et al. LANCET NEUROLOGY
- Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis
- (2014) KC Simon et al. Multiple Sclerosis Journal
- Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS
- (2014) J. F. Sumowski et al. NEUROLOGY
- Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
- (2014) P. Browne et al. NEUROLOGY
- MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
- (2013) Maria Pia Sormani et al. LANCET NEUROLOGY
- Childhood body mass index and multiple sclerosis risk: a long-term cohort study
- (2013) Kassandra L Munger et al. Multiple Sclerosis Journal
- Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial
- (2013) S Briken et al. Multiple Sclerosis Journal
- Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects
- (2013) Nikolaos A. Patsopoulos et al. PLoS Genetics
- Management options in multiple sclerosis-associated fatigue
- (2012) Maria Pia Amato et al. EXPERT OPINION ON PHARMACOTHERAPY
- Breastfeeding and multiple sclerosis relapses: a meta-analysis
- (2012) Julia Pakpoor et al. JOURNAL OF NEUROLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- Sleep disturbances in multiple sclerosis
- (2011) Ana Caminero et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Sun exposure and vitamin D are independent risk factors for CNS demyelination
- (2011) R. M. Lucas et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smoking and Multiple Sclerosis: An Updated Meta-Analysis
- (2011) Adam E. Handel et al. PLoS One
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
- (2010) Antonio Scalfari et al. BRAIN
- Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis
- (2010) R. A. Marrie et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
- (2010) Adam E. Handel et al. PLoS One
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated
- (2009) RA Marrie et al. Multiple Sclerosis Journal
- Lifetime and actual prevalence of pain and headache in multiple sclerosis
- (2008) F Martinelli Boneschi et al. Multiple Sclerosis Journal
- Prevalence of sleep problems in individuals with multiple sclerosis
- (2008) AM Bamer et al. Multiple Sclerosis Journal
- Smoking worsens the prognosis in multiple sclerosis
- (2008) P Sundström et al. Multiple Sclerosis Journal
- Comorbidity delays diagnosis and increases disability at diagnosis in MS
- (2008) R. A. Marrie et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started